Circulating concentrations of hemostatic factors and two "steroid sensitive proteins" during oral hormone replacement therapy in women with coronary heart disease

References

• Henriksson P, Blombäck M, Eriksson A, Stege R, Carlström K. Effects of parenteral oestrogen on the coagulation system in patients with prostatic carcinoma. Br J Urol 1990; 65: 282–5.
   PubMedGoogle Scholar
• Eriksson-Berg M, Silveira A, Orth-Gomér K, Hamsten A, Schenck-Gustafsson K. Coagulation factor VII in middle-aged women with and without coronary heart disease. Thromb Haemost 2002; 85: 787–92.
   Google Scholar
• De Pergola G, De Mitrio V, Perricci A. Influence of free testosterone on antigen levels of plas-minogen activator inhibitor-1 in premenopausal women with central obesity. Metabolism 1992; 41: 131 — 4.
   PubMedGoogle Scholar
• Laurell C-B, Rannevik G. A comparison of plasma protein changes induced by danazol, pregnancy, and estrogens. J Clin Endocrinol Metab 1979; 49: 719–25.
   Google Scholar
• Von Schoultz B, Carlström K, Collste L, Eriksson A, Henriksson P, Pousette A, Stege R. Estrogen therapy and liver function: metabolic effects of oral and parenteral administration. The Prostate 1989; 14: 389–95.
   PubMed Web of Science ®Google Scholar
• Lapidus L, Lindstedt G, Lundberg PA, Bengtsson C, Gredmark T. Concentrations of sex-hormone binding globulin and corticosteroid binding globulin in serum in relation to cardiovascular risk factors and to 12-year incidence of cardio-vascular disease and overall mortality in post-menopausal women. Clin Chem 1986; 32: 146–52.
   Google Scholar
• Svendsen OL, Hassager C, Christiansen C, Nielsen JD, Winther K. Plasminogen activator inhibitor-1, tissue-type plasminogen activator and fibrinogen: effect of dieting with or without exercise in overweight postmenopausal women. Arterioscler Thromb Vasc Biol 1996; 16: 381–5.
   Google Scholar
• Odlind V, Milsom I, Persson I, Victor A. Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills? Acta Obstet Gynecol Scand 2002; 81: 482–90.
   PubMed Web of Science ®Google Scholar
• Writing group for the Women's Health Initiative Investigators. Risks and benefit of estrogen plus progestin in healthy postmenopausal women. J Am Med Assoc 2002; 288: 321–33.
   Google Scholar
• Hall G, Pripp U, Schenck-Gustafsson K, Landgren B-M. Long-term effects of hormone replacement therapy on symptoms of angina pectoris, quality of life and compliance in women with coronary artery disease. Maturitas 1998; 28: 235–42.
   Google Scholar
• Pripp U, Hall G, Csemiczky G, Eksborg S, Landgren B-M, Schenck-Gustafsson K. A rando-mized trial on effects of hormone therapy on ambulatory blood pressure and lipoprotein levels in women with coronary artery disease. J Hypertens 1999; 17: 1379— 86.
   Google Scholar
• Nowinski K, Pripp U, Carlström K, Landgren B-M, Schenck-Gustafsson K, Bergfeldt L. Repolariza-tion measures and their relation to sex hormones in postmenopausal women with cardiovascular disease receiving hormone replacement therapy. Am J Cardiol 2002; 90: 1050–5.
   Google Scholar
• Tryding N, Tufvesson C, Sonntag S. Drug effects in clinical chemistry. Stockholm: Swedish Society for Clinical Chemistry, the National Corporation of Swedish Pharmacies and Pharmasoft AB. Apoteksbolaget, Förlagsavdelningen; 1996.
   Google Scholar
• Vermylen C, de Vreker R, Verstraete M. A rapid enzymatic method for assay of fibrinogen: fibrin polymerization time (FPT) test. Clin Chim Acta 1963; 8: 418–24.
   PubMed Web of Science ®Google Scholar
• Södergárd R, Bäckström T, Shanbag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradio1-1713 to plasma proteins at body temperature. J Steroid Biochem 1982; 18: 801–4.
   Google Scholar
• Poretsky L. On the paradox of insulin-induced hyperandrogenism in insulin-resistant states. Endocrine Rev 1991; 12: 3–13.
   PubMed Web of Science ®Google Scholar
• Bastard JP, Pieroni L, Hainque B. Relationship between plasminogen activator inhibitor 1 and insulin resistance. Diabetes Metab Res Rev 2000; 16: 192–201.
   Google Scholar
• Banfi C, Eriksson P, Glandomenico G. Transcrip-tional regulation of plasminogen activator inhibi-tor 1 gene by insulin: insights into the signalling pathway. Diabetes 2001; 50: 1522–30.
   Google Scholar
• Prandota J, Pankow-Prandota L, Kotecki L. Impaired activation of the fibrinolytic system in children with Henoch-Schönlein purpura: beneficial effect of hydrocortisone plus sigma-aminocaproic acid therapy on disappearance rate of cutaneous vasculitis and fibrinolysis. Am J Ther 2001; 8: 11–9.
   PubMedGoogle Scholar
• Kilger E, Weis F, Briegel J, Frey L, Goetz AE, Reuter D, Nagy A, Schuetz A, Lamm P, Knoll A, Petger K. Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 2003; 31: 1068–74.
   Google Scholar
• Yardumian A, Machin SJ. Hypercoagulable states. Int Anesthesiol Clin 1985; 23: 1441–55.
   Google Scholar
• Thornton AD, Gelehrter TD. Human hepatocytes express the gene for type 1 plasminogen activator inhibitor (PAI-1) in vivo. Fibrinolysis 1995; 9: 9 — 15.
   Google Scholar
• Plymate SR, Matej LA, Jones RE, Friedl KE. Inhibition of sex hormone-binding globulin pro-duction in human hepatoma (HepG2) cell line by insulin and prolactin. J Clin Endocrinol Metab 1988; 67: 460–4.
   PubMed Web of Science ®Google Scholar
• Kilboume EJ, Scicchitano MS. The activation of plasminogen activator inhibitor 1 expression: IL 1 beta is attenuated by estrogen in hepatoblastoma HepEG2 cells expressing estrogen receptor alpha. Thromb Haemost 1999; 81: 423–7.
   PubMedGoogle Scholar
• Lundgren S, banning PE, Utaaker E, Aakvaag A, Kvinsland S. Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer-I. General findings. J Steroid Biochem 1990; 36: 99–104.
   Google Scholar
• Henrikson P, Blombäck M, Bratt G, Edhag 0, Eriksson A. Activators and inhibitors of coagula-tion and fibrinolysis in patients with prostatic cancer treated with oestrogen or orchidectomy. Thrombosis Res 1986; 44: 783–91.
   Google Scholar
• Van Rooijen M, von Schoultz B, Silveira A, Hamsten A, Bremme K. Different effects of oral contraceptives containing levonorgestrel or deso-gestrel on plasma lipoproteins and coagulation factor VII. Am J Obstet Gynecol 2002; 186: 44–8.
   PubMed Web of Science ®Google Scholar